Crossmark

GPC2 provides prognostic value in pan-pediatric cancers and is associated with MYCN amplification in neuroblastoma: bioinformatics analysis and validation

Crossref DOI link: https://doi.org/10.1186/s12885-026-15820-x

Published Online: 2026-03-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Yanfeng

Zhou, Ziang

Dong, Yanqun

Wang, Guanyun

Zheng, Lingling

Lu, Xia

Li, Siqi

Zhang, Mingyu

Gong, Jianhua

Yang, Jigang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82572264)

Natural Science Foundation of Beijing Municipality (L248065)
License Information

Text and Data Mining valid from 2026-03-17

Version of Record valid from 2026-04-24
More Information

Article History

Received: 11 October 2024

Accepted: 27 February 2026

First Online: 17 March 2026

Declarations

:

: The local Ethics Committee of Beijing Friendship Hospital approved this study. Informed consent was obtained from the parents or legal guardians of all participants in the study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below